Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic’s Guardian “Real-Time” Glucose Monitor Receives FDA Approval

This article was originally published in The Gray Sheet

Executive Summary

FDA approval of the Guardian RT continuous glucose monitoring system bodes well for the regulatory success of an integrated insulin pump-glucose monitoring product, Medtronic says

You may also be interested in...



Good Algorithms, Documentation Needed For Artificial Pancreas Approval

Proper algorithm development and software documentation are key components to ensuring a strong premarket submission for artificial pancreas devices, a CDRH scientist says

Good Algorithms, Documentation Needed For Artificial Pancreas Approval

Proper algorithm development and software documentation are key components to ensuring a strong premarket submission for artificial pancreas devices, a CDRH scientist says

Diabetes Groups Seek Yardstick For Continuous Glucose Monitoring

Two nonprofit groups will collaborate to develop a set of standards for evaluating results from continuous glucose monitors manufactured by different companies

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel